Publications

Select publications using tissue samples and resources from the St. Louis Breast Tissue Registry are highlighted below. Apply for full tissue sections or tissue microarrays.

Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, Colditz GA, DeSchryver K, Wilson RK, Mardis ER, Ellis MJ. Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nat Commun.2016 Aug 9;7:12498. doi: 10.1038/ncomms12498. PubMed PMID: 27502118; PubMed Central PMCID: PMC4980485.

Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007 Mar;11(3):259-73. PMID: 17349583.

Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, Russell RG, Cvekl A, Pestell RG. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol. 2006 Oct;26(19):7116-29.

 
Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, Delellis RA, Steinhoff MM, Sabo E. Distribution of GPR30, a Seven Membrane-Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression. Clin Cancer Res. 2006 Nov 1;12(21):6359-66. PMID: 17085646.

 

Henke RT, Eun Kim S, Maitra A, Paik S, Wellstein A. Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization. Methods. 2006 Apr;38(4):253-62. PMID: 16513366.

Portera CC, Yang SX, Wedam SB, Nguyen D, Vatas U, Takikita M, Hewitt SM, Liewehr DJ, Steinberg SM, Sherman M, Levine PH, Swain SM. Evaluation of E-cadherin expression and lymphatic involvement in inflammatory breast cancer. Session Info: Poster Session IV: Detection and Diagnosis: Diagnostic Pathology. SABCS 2006.

Perez EA. HER-2 as a Prognostic, Predictive, and Therapeutic Target in Breast Cancer. Cancer Control. 1999 May;6(3):233-240. PMID: 10758552.

Download more publications utilizing the St. Louis Breast Tissue Registry.